体外循環装置の世界市場レポート2026-2032

QY Research > レポート一覧 > 医療機器と消耗材 > 体外循環装置の世界市場レポート2026-2032

英文タイトル： Global Cardiopulmonary Bypass Equipment Market Research Report 2026

レポートID：1608497
発表時期：2026-07-11
訪問回数：244
ページ数：114
レポート形式：PDF
レポート言語：英語、日本語
グラフ数：108
レポートカテゴリ：医療機器と消耗材

販売価格（消費税別）

個人版
詳細
マルチユーザー版
詳細
企業版
詳細

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.70円。
※米ドル表示価格+10％消費税。

英語版

日本語版

英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.70円。
※米ドル表示価格+10％消費税。

お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合，注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。但し、日本語版が必要な場合は、受注後8～10営業日となります。お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

概要

世界の体外循環装置市場は、2025年に550百万米ドルと算定されており、2026年には598百万米ドルとなる見通しです。2026年から2032年の期間においては年平均成長率（CAGR）9.7%で推移し、2032年には1042百万米ドルに達すると予測されています。

本レポートは、体外循環装置メーカー、新規参入企業、および業界バリューチェーン全体の企業に対し、市場全体およびサブセグメント別の収益、生産量、平均価格に関する情報を、企業別、タイプ別、用途別、地域別に提供します。
世界の体外循環装置市場について、定量的・定性的分析を交えた包括的な概観を提供し、企業関係者が成長戦略の策定、競争環境の評価、現行市場における自社の位置付けの分析、体外循環装置に関する情報に基づいたビジネス判断を行うことを支援します。体外循環装置市場の規模、推定値及び予測値の観点から提示し、2025年を基準年として、2021年から2032年までの過去データ及び予測データを収録しております。

報告対象範囲
売上高・数量予測、企業シェア、競争環境、成長要因および市場トレンド

市場セグメンテーション
企業一覧
Sorin Group
LivaNova
Medtronic
Terumo Cardiovascular
Fresenius Medical Care
Getinge
Braile Biomedica
Chalice Medical
Tianjin Medical

タイプ別
Single Roller Pump Cardiopulmonary Bypass Equipment
Double Roller Pump Cardiopulmonary Bypass Equipment

用途別
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others

製品カテゴリー

市場セグメント
Cardiac Surgery Department
Perfusion Department
Hybrid OR
Specialist Heart Center
Other

地域別
北米（アメリカ、カナダ、メキシコ）
欧州（ドイツ、フランス、イギリス、イタリアなど）
アジア太平洋（中国、日本、韓国、東南アジア、インドなど）
南米（ブラジルなど）
中東・アフリカ（トルコ、GCC諸国、アフリカなど）
本レポートは、世界の体外循環装置市場を包括的にセグメント化しております。地域別市場規模、タイプ別、用途別、企業別の市場規模も提供されます。より深い洞察を得るため、競争環境、主要競合他社、それぞれの市場順位をプロファイリングし、技術動向や新製品開発についても論じております。

本レポートの構成
第1章：体外循環装置の定義および調査範囲を明確化し、市場セグメント（タイプ別、用途別など）の概要を提示します。各セグメントの市場規模と将来の成長可能性を網羅し、現在の市場状況の概要を提供するとともに、短期・中期・長期の発展トレンドを分析します
第2章：体外循環装置メーカーの競争環境について、価格、生産量、価値ベースの市場シェア、最新の開発計画、合併・買収情報を含め詳細に分析します
第3章：体外循環装置の生産量／生産高および価値を地域・国別に検証し、今後6年間の各地域の市場規模と成長可能性について定量的な評価を提供します
第4章：地域および国レベルでの体外循環装置の消費動向を分析します。各地域および主要国における市場規模と成長可能性を定量化し、市場開発状況、見通し、対応可能な市場規模、国内生産量を概説します
第5章：体外循環装置に基づくタイプ別市場セグメントの構造を整理し、各セグメントの市場規模と成長ポテンシャルを明確化することで、企業・投資家によるブルーオーシャン機会の発見を支援します
第6章：用途別に体外循環装置の市場セグメントを整理し、各分野の市場規模、成長ポテンシャル、需要拡大余地を提示することで、下流市場における有望な参入機会や競争優位の確立に向けた判断材料を提供します
第7章：体外循環装置の主要プレイヤーを分析し、主要企業の基本情報（製品生産量／生産高、価値、価格、粗利益率、製品ポートフォリオ／新製品導入、最近の動向）を詳細に説明します
第8章：体外循環装置の上流および下流セグメントを含む業界バリューチェーンをレビューします
第9章：体外循環装置市場の動向と最新トレンドについて議論します。これには、メーカーにとっての推進要因、制約要因、課題、リスク、米国関税、関連政策分析が含まれます
第10章：主な調査結果と結論をまとめます
第11章：付録

Description

The global Cardiopulmonary Bypass Equipment market was valued at US$ 550 million in 2025 and is anticipated to reach US$ 1042 million by 2032, at a CAGR of 9.7% from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Cardiopulmonary Bypass Equipment competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Cardiopulmonary Bypass Equipment refers to a life-support system designed to temporarily replace or assist the pumping function of the heart and the gas-exchange function of the lungs during open-heart and selected major vascular procedures. Its central component is generally a heart-lung machine, which removes venous blood from the patient, pumps it through an oxygenator for oxygenation and carbon-dioxide removal, and returns it to the arterial circulation. This process maintains systemic perfusion while the heart is stopped or blood flow is interrupted. A complete system typically includes roller or centrifugal pumps, a central control console, monitoring modules, heater-cooler units and gas-blending devices, operating together with disposable oxygenators, reservoirs, tubing sets, cannulae and filters. The equipment is primarily used in coronary artery bypass grafting, valve repair or replacement, congenital heart surgery, aortic procedures and cardiopulmonary transplantation. It must provide highly reliable control of blood flow, temperature, pressure, air detection, patient monitoring and procedural data.In 2025, global Cardiopulmonary Bypass Equipment production reached approximately 2000 units.The average gross profit margin of this product is 55%.

Population aging, the increasing prevalence of coronary and valvular heart disease, and the expansion of complex cardiac surgery into more regional medical centers are supporting sustained demand for cardiopulmonary bypass equipment. Although interventional and minimally invasive therapies are replacing surgery in selected patients, complex coronary lesions, multivalvular disease, congenital defects and major aortic disorders still require extracorporeal circulation. Hospitals are also replacing aging heart-lung machines and shifting purchasing priorities from basic pumping capability toward integrated monitoring, automated safety control and digital perfusion management. Embedded patient monitoring, advanced sensors and procedural data integration are extending product value from capital equipment into consumables, software, maintenance and clinical services.
Because cardiopulmonary bypass equipment directly supports blood circulation, failures involving pump speed, air management, temperature control or monitoring can have severe clinical consequences. Manufacturers must therefore complete extensive testing covering biocompatibility, mechanical integrity, blood damage, air entrapment, reliability and sterilization, while managing lengthy regulatory and hospital-approval processes. High acquisition costs, complex cardiac-surgery training requirements and shortages of qualified perfusion personnel can constrain adoption in smaller hospitals. Product recalls and component shortages may also damage customer confidence, making robust quality systems, preventive maintenance and responsive technical support essential competitive requirements.
Downstream purchasing is shifting from standalone heart-lung machines toward integrated combinations of equipment, disposables, clinical data and services. Major cardiac centers increasingly require real-time monitoring of flow, pressure, temperature, blood gases and reservoir levels, together with connectivity to hospital information systems. Pediatric cardiac programs place additional emphasis on low-prime circuits and precise flow control to reduce hemodilution and blood trauma. Standardized interfaces, automated warnings, electronic case documentation, remote diagnostics and clinical training are also becoming more important. Systems that simplify operation and improve consistency between perfusion teams are therefore likely to capture stronger replacement demand.

This report delivers a comprehensive overview of the global Cardiopulmonary Bypass Equipment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cardiopulmonary Bypass Equipment. The Cardiopulmonary Bypass Equipment market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Cardiopulmonary Bypass Equipment market comprehensively. Regional market sizes by Type, by Application, by Surgical Procedure, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cardiopulmonary Bypass Equipment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation
By Company
Sorin Group
LivaNova
Medtronic
Terumo Cardiovascular
Fresenius Medical Care
Getinge
Braile Biomedica
Chalice Medical
Tianjin Medical

Segment by Type
Single Roller Pump Cardiopulmonary Bypass Equipment
Double Roller Pump Cardiopulmonary Bypass Equipment

Segment by Surgical Procedure
Cardiac Surgery
Valve Surgery
CABG Surgery
Aortic Surgery
Other

Segment by Hospital Department
Cardiac Surgery Department
Perfusion Department
Hybrid OR
Specialist Heart Center
Other

by Application
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others

Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Surgical Procedure, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Cardiopulmonary Bypass Equipment manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Cardiopulmonary Bypass Equipment sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

Table of Contents

1 Cardiopulmonary Bypass Equipment Market Overview
1.1 Product Definition
1.2 Cardiopulmonary Bypass Equipment by Type
1.2.1 Global Cardiopulmonary Bypass Equipment Market Value by Type: 2025 vs 2032
1.2.2 Single Roller Pump Cardiopulmonary Bypass Equipment
1.2.3 Double Roller Pump Cardiopulmonary Bypass Equipment
1.3 Cardiopulmonary Bypass Equipment by Surgical Procedure
1.3.1 Global Cardiopulmonary Bypass Equipment Market Value by Surgical Procedure: 2025 vs 2032
1.3.2 Cardiac Surgery
1.3.3 Valve Surgery
1.3.4 CABG Surgery
1.3.5 Aortic Surgery
1.3.6 Other
1.4 Cardiopulmonary Bypass Equipment by Hospital Department
1.4.1 Global Cardiopulmonary Bypass Equipment Market Value by Hospital Department: 2025 vs 2032
1.4.2 Cardiac Surgery Department
1.4.3 Perfusion Department
1.4.4 Hybrid OR
1.4.5 Specialist Heart Center
1.4.6 Other
1.5 Cardiopulmonary Bypass Equipment by Application
1.5.1 Global Cardiopulmonary Bypass Equipment Market Value by Application: 2025 vs 2032
1.5.2 Cardiac Surgery
1.5.3 Lung Transplant Operation
1.5.4 Acute Respiratory Failure Treatment
1.5.5 Others
1.6 Global Cardiopulmonary Bypass Equipment Market Size Estimates and Forecasts
1.6.1 Global Cardiopulmonary Bypass Equipment Revenue 2021–2032
1.6.2 Global Cardiopulmonary Bypass Equipment Sales 2021–2032
1.6.3 Global Cardiopulmonary Bypass Equipment Market Average Price (2021–2032)
1.7 Assumptions and Limitations

2 Cardiopulmonary Bypass Equipment Market Competition by Manufacturers
2.1 Global Cardiopulmonary Bypass Equipment Sales Market Share by Manufacturers (2021–2026)
2.2 Global Cardiopulmonary Bypass Equipment Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Cardiopulmonary Bypass Equipment Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Cardiopulmonary Bypass Equipment, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Cardiopulmonary Bypass Equipment, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Cardiopulmonary Bypass Equipment, Product Types and Applications
2.7 Global Key Manufacturers of Cardiopulmonary Bypass Equipment, Date of Entry into the Industry
2.8 Global Cardiopulmonary Bypass Equipment Market Competitive Situation and Trends
2.8.1 Global Cardiopulmonary Bypass Equipment Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Cardiopulmonary Bypass Equipment Players Market Share by Revenue
2.8.3 Global Cardiopulmonary Bypass Equipment Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Cardiopulmonary Bypass Equipment Market Scenario by Region
3.1 Global Cardiopulmonary Bypass Equipment Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Cardiopulmonary Bypass Equipment Sales by Region: 2021–2032
3.2.1 Global Cardiopulmonary Bypass Equipment Sales by Region: 2021–2026
3.2.2 Global Cardiopulmonary Bypass Equipment Sales by Region: 2027–2032
3.3 Global Cardiopulmonary Bypass Equipment Revenue by Region: 2021–2032
3.3.1 Global Cardiopulmonary Bypass Equipment Revenue by Region: 2021–2026
3.3.2 Global Cardiopulmonary Bypass Equipment Revenue by Region: 2027–2032
3.4 North America Cardiopulmonary Bypass Equipment Market Facts & Figures by Country
3.4.1 North America Cardiopulmonary Bypass Equipment Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Cardiopulmonary Bypass Equipment Sales by Country (2021–2032)
3.4.3 North America Cardiopulmonary Bypass Equipment Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cardiopulmonary Bypass Equipment Market Facts & Figures by Country
3.5.1 Europe Cardiopulmonary Bypass Equipment Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Cardiopulmonary Bypass Equipment Sales by Country (2021–2032)
3.5.3 Europe Cardiopulmonary Bypass Equipment Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardiopulmonary Bypass Equipment Market Facts & Figures by Region
3.6.1 Asia Pacific Cardiopulmonary Bypass Equipment Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Cardiopulmonary Bypass Equipment Sales by Region (2021–2032)
3.6.3 Asia Pacific Cardiopulmonary Bypass Equipment Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cardiopulmonary Bypass Equipment Market Facts & Figures by Country
3.7.1 Latin America Cardiopulmonary Bypass Equipment Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Cardiopulmonary Bypass Equipment Sales by Country (2021–2032)
3.7.3 Latin America Cardiopulmonary Bypass Equipment Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cardiopulmonary Bypass Equipment Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardiopulmonary Bypass Equipment Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Cardiopulmonary Bypass Equipment Sales by Country (2021–2032)
3.8.3 Middle East and Africa Cardiopulmonary Bypass Equipment Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE

4 Segment by Type
4.1 Global Cardiopulmonary Bypass Equipment Sales by Type (2021–2032)
4.1.1 Global Cardiopulmonary Bypass Equipment Sales by Type (2021–2026)
4.1.2 Global Cardiopulmonary Bypass Equipment Sales by Type (2027–2032)
4.1.3 Global Cardiopulmonary Bypass Equipment Sales Market Share by Type (2021–2032)
4.2 Global Cardiopulmonary Bypass Equipment Revenue by Type (2021–2032)
4.2.1 Global Cardiopulmonary Bypass Equipment Revenue by Type (2021–2026)
4.2.2 Global Cardiopulmonary Bypass Equipment Revenue by Type (2027–2032)
4.2.3 Global Cardiopulmonary Bypass Equipment Revenue Market Share by Type (2021–2032)
4.3 Global Cardiopulmonary Bypass Equipment Price by Type (2021–2032)

5 Segment by Application
5.1 Global Cardiopulmonary Bypass Equipment Sales by Application (2021–2032)
5.1.1 Global Cardiopulmonary Bypass Equipment Sales by Application (2021–2026)
5.1.2 Global Cardiopulmonary Bypass Equipment Sales by Application (2027–2032)
5.1.3 Global Cardiopulmonary Bypass Equipment Sales Market Share by Application (2021–2032)
5.2 Global Cardiopulmonary Bypass Equipment Revenue by Application (2021–2032)
5.2.1 Global Cardiopulmonary Bypass Equipment Revenue by Application (2021–2026)
5.2.2 Global Cardiopulmonary Bypass Equipment Revenue by Application (2027–2032)
5.2.3 Global Cardiopulmonary Bypass Equipment Revenue Market Share by Application (2021–2032)
5.3 Global Cardiopulmonary Bypass Equipment Price by Application (2021–2032)

6 Key Companies Profiled
6.1 Sorin Group
6.1.1 Sorin Group Company Information
6.1.2 Sorin Group Description and Business Overview
6.1.3 Sorin Group Cardiopulmonary Bypass Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sorin Group Cardiopulmonary Bypass Equipment Product Portfolio
6.1.5 Sorin Group Recent Developments/Updates
6.2 LivaNova
6.2.1 LivaNova Company Information
6.2.2 LivaNova Description and Business Overview
6.2.3 LivaNova Cardiopulmonary Bypass Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 LivaNova Cardiopulmonary Bypass Equipment Product Portfolio
6.2.5 LivaNova Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Cardiopulmonary Bypass Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Medtronic Cardiopulmonary Bypass Equipment Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Terumo Cardiovascular
6.4.1 Terumo Cardiovascular Company Information
6.4.2 Terumo Cardiovascular Description and Business Overview
6.4.3 Terumo Cardiovascular Cardiopulmonary Bypass Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Terumo Cardiovascular Cardiopulmonary Bypass Equipment Product Portfolio
6.4.5 Terumo Cardiovascular Recent Developments/Updates
6.5 Fresenius Medical Care
6.5.1 Fresenius Medical Care Company Information
6.5.2 Fresenius Medical Care Description and Business Overview
6.5.3 Fresenius Medical Care Cardiopulmonary Bypass Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Fresenius Medical Care Cardiopulmonary Bypass Equipment Product Portfolio
6.5.5 Fresenius Medical Care Recent Developments/Updates
6.6 Getinge
6.6.1 Getinge Company Information
6.6.2 Getinge Description and Business Overview
6.6.3 Getinge Cardiopulmonary Bypass Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Getinge Cardiopulmonary Bypass Equipment Product Portfolio
6.6.5 Getinge Recent Developments/Updates
6.7 Braile Biomedica
6.7.1 Braile Biomedica Company Information
6.7.2 Braile Biomedica Description and Business Overview
6.7.3 Braile Biomedica Cardiopulmonary Bypass Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Braile Biomedica Cardiopulmonary Bypass Equipment Product Portfolio
6.7.5 Braile Biomedica Recent Developments/Updates
6.8 Chalice Medical
6.8.1 Chalice Medical Company Information
6.8.2 Chalice Medical Description and Business Overview
6.8.3 Chalice Medical Cardiopulmonary Bypass Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Chalice Medical Cardiopulmonary Bypass Equipment Product Portfolio
6.8.5 Chalice Medical Recent Developments/Updates
6.9 Tianjin Medical
6.9.1 Tianjin Medical Company Information
6.9.2 Tianjin Medical Description and Business Overview
6.9.3 Tianjin Medical Cardiopulmonary Bypass Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Tianjin Medical Cardiopulmonary Bypass Equipment Product Portfolio
6.9.5 Tianjin Medical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis
7.1 Cardiopulmonary Bypass Equipment Industry Chain Analysis
7.2 Cardiopulmonary Bypass Equipment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardiopulmonary Bypass Equipment Production Mode & Process Analysis
7.4 Cardiopulmonary Bypass Equipment Sales and Marketing
7.4.1 Cardiopulmonary Bypass Equipment Sales Channels
7.4.2 Cardiopulmonary Bypass Equipment Distributors
7.5 Cardiopulmonary Bypass Equipment Customer Analysis

8 Cardiopulmonary Bypass Equipment Market Dynamics
8.1 Cardiopulmonary Bypass Equipment Industry Trends
8.2 Cardiopulmonary Bypass Equipment Market Drivers
8.3 Cardiopulmonary Bypass Equipment Market Challenges
8.4 Cardiopulmonary Bypass Equipment Market Restraints
8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Cardiopulmonary Bypass Equipment Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Cardiopulmonary Bypass Equipment Market Value by Surgical Procedure (US$ Million), 2025 vs 2032
 Table 3. Global Cardiopulmonary Bypass Equipment Market Value by Hospital Department (US$ Million), 2025 vs 2032
 Table 4. Global Cardiopulmonary Bypass Equipment Market Value by Application (US$ Million), 2025 vs 2032
 Table 5. Global Cardiopulmonary Bypass Equipment Market Competitive Situation by Manufacturers in 2025
 Table 6. Global Cardiopulmonary Bypass Equipment Sales (Units) of Key Manufacturers (2021–2026)
 Table 7. Global Cardiopulmonary Bypass Equipment Sales Market Share by Manufacturers (2021–2026)
 Table 8. Global Cardiopulmonary Bypass Equipment Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 9. Global Cardiopulmonary Bypass Equipment Revenue Share by Manufacturers (2021–2026)
 Table 10. Global Market Cardiopulmonary Bypass Equipment Average Price (K USD/Unit) of Key Manufacturers (2021–2026)
 Table 11. Global Key Players of Cardiopulmonary Bypass Equipment, Industry Ranking, 2023 vs 2024 vs 2025
 Table 12. Global Key Manufacturers of Cardiopulmonary Bypass Equipment, Manufacturing Sites and Headquarters
 Table 13. Global Key Manufacturers of Cardiopulmonary Bypass Equipment, Product Types and Applications
 Table 14. Global Key Manufacturers of Cardiopulmonary Bypass Equipment, Date of Entry into the Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Cardiopulmonary Bypass Equipment Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cardiopulmonary Bypass Equipment Revenue, 2025
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Cardiopulmonary Bypass Equipment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 19. Global Cardiopulmonary Bypass Equipment Sales by Region (Units), 2021–2026
 Table 20. Global Cardiopulmonary Bypass Equipment Sales Market Share by Region (2021–2026)
 Table 21. Global Cardiopulmonary Bypass Equipment Sales by Region (Units), 2027–2032
 Table 22. Global Cardiopulmonary Bypass Equipment Sales Market Share by Region (2027–2032)
 Table 23. Global Cardiopulmonary Bypass Equipment Revenue by Region (US$ Million), 2021–2026
 Table 24. Global Cardiopulmonary Bypass Equipment Revenue Market Share by Region (2021–2026)
 Table 25. Global Cardiopulmonary Bypass Equipment Revenue by Region (US$ Million), 2027–2032
 Table 26. Global Cardiopulmonary Bypass Equipment Revenue Market Share by Region (2027–2032)
 Table 27. North America Cardiopulmonary Bypass Equipment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 28. North America Cardiopulmonary Bypass Equipment Sales by Country (Units), 2021–2026
 Table 29. North America Cardiopulmonary Bypass Equipment Sales by Country (Units), 2027–2032
 Table 30. North America Cardiopulmonary Bypass Equipment Revenue by Country (US$ Million), 2021–2026
 Table 31. North America Cardiopulmonary Bypass Equipment Revenue by Country (US$ Million), 2027–2032
 Table 32. Europe Cardiopulmonary Bypass Equipment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 33. Europe Cardiopulmonary Bypass Equipment Sales by Country (Units), 2021–2026
 Table 34. Europe Cardiopulmonary Bypass Equipment Sales by Country (Units), 2027–2032
 Table 35. Europe Cardiopulmonary Bypass Equipment Revenue by Country (US$ Million), 2021–2026
 Table 36. Europe Cardiopulmonary Bypass Equipment Revenue by Country (US$ Million), 2027–2032
 Table 37. Asia Pacific Cardiopulmonary Bypass Equipment Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 38. Asia Pacific Cardiopulmonary Bypass Equipment Sales by Region (Units), 2021–2026
 Table 39. Asia Pacific Cardiopulmonary Bypass Equipment Sales by Region (Units), 2027–2032
 Table 40. Asia Pacific Cardiopulmonary Bypass Equipment Revenue by Region (US$ Million), 2021–2026
 Table 41. Asia Pacific Cardiopulmonary Bypass Equipment Revenue by Region (US$ Million), 2027–2032
 Table 42. Latin America Cardiopulmonary Bypass Equipment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 43. Latin America Cardiopulmonary Bypass Equipment Sales by Country (Units), 2021–2026
 Table 44. Latin America Cardiopulmonary Bypass Equipment Sales by Country (Units), 2027–2032
 Table 45. Latin America Cardiopulmonary Bypass Equipment Revenue by Country (US$ Million), 2021–2026
 Table 46. Latin America Cardiopulmonary Bypass Equipment Revenue by Country (US$ Million), 2027–2032
 Table 47. Middle East and Africa Cardiopulmonary Bypass Equipment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 48. Middle East and Africa Cardiopulmonary Bypass Equipment Sales by Country (Units), 2021–2026
 Table 49. Middle East and Africa Cardiopulmonary Bypass Equipment Sales by Country (Units), 2027–2032
 Table 50. Middle East and Africa Cardiopulmonary Bypass Equipment Revenue by Country (US$ Million), 2021–2026
 Table 51. Middle East and Africa Cardiopulmonary Bypass Equipment Revenue by Country (US$ Million), 2027–2032
 Table 52. Global Cardiopulmonary Bypass Equipment Sales (Units) by Type (2021–2026)
 Table 53. Global Cardiopulmonary Bypass Equipment Sales (Units) by Type (2027–2032)
 Table 54. Global Cardiopulmonary Bypass Equipment Sales Market Share by Type (2021–2026)
 Table 55. Global Cardiopulmonary Bypass Equipment Sales Market Share by Type (2027–2032)
 Table 56. Global Cardiopulmonary Bypass Equipment Revenue (US$ Million) by Type (2021–2026)
 Table 57. Global Cardiopulmonary Bypass Equipment Revenue (US$ Million) by Type (2027–2032)
 Table 58. Global Cardiopulmonary Bypass Equipment Revenue Market Share by Type (2021–2026)
 Table 59. Global Cardiopulmonary Bypass Equipment Revenue Market Share by Type (2027–2032)
 Table 60. Global Cardiopulmonary Bypass Equipment Price (K USD/Unit) by Type (2021–2026)
 Table 61. Global Cardiopulmonary Bypass Equipment Price (K USD/Unit) by Type (2027–2032)
 Table 62. Global Cardiopulmonary Bypass Equipment Sales (Units) by Application (2021–2026)
 Table 63. Global Cardiopulmonary Bypass Equipment Sales (Units) by Application (2027–2032)
 Table 64. Global Cardiopulmonary Bypass Equipment Sales Market Share by Application (2021–2026)
 Table 65. Global Cardiopulmonary Bypass Equipment Sales Market Share by Application (2027–2032)
 Table 66. Global Cardiopulmonary Bypass Equipment Revenue (US$ Million) by Application (2021–2026)
 Table 67. Global Cardiopulmonary Bypass Equipment Revenue (US$ Million) by Application (2027–2032)
 Table 68. Global Cardiopulmonary Bypass Equipment Revenue Market Share by Application (2021–2026)
 Table 69. Global Cardiopulmonary Bypass Equipment Revenue Market Share by Application (2027–2032)
 Table 70. Global Cardiopulmonary Bypass Equipment Price (K USD/Unit) by Application (2021–2026)
 Table 71. Global Cardiopulmonary Bypass Equipment Price (K USD/Unit) by Application (2027–2032)
 Table 72. Sorin Group Company Information
 Table 73. Sorin Group Description and Business Overview
 Table 74. Sorin Group Cardiopulmonary Bypass Equipment Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
 Table 75. Sorin Group Cardiopulmonary Bypass Equipment Product
 Table 76. Sorin Group Recent Developments/Updates
 Table 77. LivaNova Company Information
 Table 78. LivaNova Description and Business Overview
 Table 79. LivaNova Cardiopulmonary Bypass Equipment Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
 Table 80. LivaNova Cardiopulmonary Bypass Equipment Product
 Table 81. LivaNova Recent Developments/Updates
 Table 82. Medtronic Company Information
 Table 83. Medtronic Description and Business Overview
 Table 84. Medtronic Cardiopulmonary Bypass Equipment Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
 Table 85. Medtronic Cardiopulmonary Bypass Equipment Product
 Table 86. Medtronic Recent Developments/Updates
 Table 87. Terumo Cardiovascular Company Information
 Table 88. Terumo Cardiovascular Description and Business Overview
 Table 89. Terumo Cardiovascular Cardiopulmonary Bypass Equipment Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
 Table 90. Terumo Cardiovascular Cardiopulmonary Bypass Equipment Product
 Table 91. Terumo Cardiovascular Recent Developments/Updates
 Table 92. Fresenius Medical Care Company Information
 Table 93. Fresenius Medical Care Description and Business Overview
 Table 94. Fresenius Medical Care Cardiopulmonary Bypass Equipment Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
 Table 95. Fresenius Medical Care Cardiopulmonary Bypass Equipment Product
 Table 96. Fresenius Medical Care Recent Developments/Updates
 Table 97. Getinge Company Information
 Table 98. Getinge Description and Business Overview
 Table 99. Getinge Cardiopulmonary Bypass Equipment Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
 Table 100. Getinge Cardiopulmonary Bypass Equipment Product
 Table 101. Getinge Recent Developments/Updates
 Table 102. Braile Biomedica Company Information
 Table 103. Braile Biomedica Description and Business Overview
 Table 104. Braile Biomedica Cardiopulmonary Bypass Equipment Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
 Table 105. Braile Biomedica Cardiopulmonary Bypass Equipment Product
 Table 106. Braile Biomedica Recent Developments/Updates
 Table 107. Chalice Medical Company Information
 Table 108. Chalice Medical Description and Business Overview
 Table 109. Chalice Medical Cardiopulmonary Bypass Equipment Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
 Table 110. Chalice Medical Cardiopulmonary Bypass Equipment Product
 Table 111. Chalice Medical Recent Developments/Updates
 Table 112. Tianjin Medical Company Information
 Table 113. Tianjin Medical Description and Business Overview
 Table 114. Tianjin Medical Cardiopulmonary Bypass Equipment Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
 Table 115. Tianjin Medical Cardiopulmonary Bypass Equipment Product
 Table 116. Tianjin Medical Recent Developments/Updates
 Table 117. Key Raw Materials Lists
 Table 118. Raw Materials Key Suppliers Lists
 Table 119. Cardiopulmonary Bypass Equipment Distributors List
 Table 120. Cardiopulmonary Bypass Equipment Customers List
 Table 121. Cardiopulmonary Bypass Equipment Market Trends
 Table 122. Cardiopulmonary Bypass Equipment Market Drivers
 Table 123. Cardiopulmonary Bypass Equipment Market Challenges
 Table 124. Cardiopulmonary Bypass Equipment Market Restraints
 Table 125. Research Programs/Design for This Report
 Table 126. Key Data Information from Secondary Sources
 Table 127. Key Data Information from Primary Sources
 Table 128. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cardiopulmonary Bypass Equipment
 Figure 2. Global Cardiopulmonary Bypass Equipment Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Cardiopulmonary Bypass Equipment Market Share by Type: 2025 & 2032
 Figure 4. Single Roller Pump Cardiopulmonary Bypass Equipment Product Picture
 Figure 5. Double Roller Pump Cardiopulmonary Bypass Equipment Product Picture
 Figure 6. Global Cardiopulmonary Bypass Equipment Market Value by Surgical Procedure (US$ Million), 2021–2032
 Figure 7. Global Cardiopulmonary Bypass Equipment Market Share by Surgical Procedure: 2025 vs 2032
 Figure 8. Cardiac Surgery Product Picture
 Figure 9. Valve Surgery Product Picture
 Figure 10. CABG Surgery Product Picture
 Figure 11. Aortic Surgery Product Picture
 Figure 12. Other Product Picture
 Figure 13. Global Cardiopulmonary Bypass Equipment Market Value by Hospital Department (US$ Million), 2021–2032
 Figure 14. Global Cardiopulmonary Bypass Equipment Market Share by Hospital Department: 2025 vs 2032
 Figure 15. Cardiac Surgery Department Product Picture
 Figure 16. Perfusion Department Product Picture
 Figure 17. Hybrid OR Product Picture
 Figure 18. Specialist Heart Center Product Picture
 Figure 19. Other Product Picture
 Figure 20. Global Cardiopulmonary Bypass Equipment Market Value by Application (US$ Million), 2021–2032
 Figure 21. Global Cardiopulmonary Bypass Equipment Market Share by Application: 2025 & 2032
 Figure 22. Cardiac Surgery
 Figure 23. Lung Transplant Operation
 Figure 24. Acute Respiratory Failure Treatment
 Figure 25. Others
 Figure 26. Global Cardiopulmonary Bypass Equipment Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 27. Global Cardiopulmonary Bypass Equipment Market Size (US$ Million), 2021–2032
 Figure 28. Global Cardiopulmonary Bypass Equipment Sales (Units), 2021–2032
 Figure 29. Global Cardiopulmonary Bypass Equipment Average Price (K USD/Unit), 2021–2032
 Figure 30. Cardiopulmonary Bypass Equipment Report Years Considered
 Figure 31. Cardiopulmonary Bypass Equipment Sales Share by Manufacturers in 2025
 Figure 32. Global Cardiopulmonary Bypass Equipment Revenue Share by Manufacturers in 2025
 Figure 33. Top 5 and Top 10 Global Cardiopulmonary Bypass Equipment Players: Market Share by Revenue in Cardiopulmonary Bypass Equipment in 2025
 Figure 34. Cardiopulmonary Bypass Equipment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 35. Global Cardiopulmonary Bypass Equipment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 36. North America Cardiopulmonary Bypass Equipment Sales Market Share by Country (2021–2032)
 Figure 37. North America Cardiopulmonary Bypass Equipment Revenue Market Share by Country (2021–2032)
 Figure 38. U.S. Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Canada Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Europe Cardiopulmonary Bypass Equipment Sales Market Share by Country (2021–2032)
 Figure 41. Europe Cardiopulmonary Bypass Equipment Revenue Market Share by Country (2021–2032)
 Figure 42. Germany Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. France Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. U.K. Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Italy Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Russia Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Asia Pacific Cardiopulmonary Bypass Equipment Sales Market Share by Region (2021–2032)
 Figure 48. Asia Pacific Cardiopulmonary Bypass Equipment Revenue Market Share by Region (2021–2032)
 Figure 49. China Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Japan Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. South Korea Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. India Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Australia Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. China Taiwan Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Indonesia Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Thailand Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Malaysia Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. Latin America Cardiopulmonary Bypass Equipment Sales Market Share by Country (2021–2032)
 Figure 59. Latin America Cardiopulmonary Bypass Equipment Revenue Market Share by Country (2021–2032)
 Figure 60. Mexico Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 61. Brazil Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 62. Argentina Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 63. Middle East and Africa Cardiopulmonary Bypass Equipment Sales Market Share by Country (2021–2032)
 Figure 64. Middle East and Africa Cardiopulmonary Bypass Equipment Revenue Market Share by Country (2021–2032)
 Figure 65. Turkey Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 66. Saudi Arabia Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 67. UAE Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 68. Global Sales Market Share of Cardiopulmonary Bypass Equipment by Type (2021–2032)
 Figure 69. Global Revenue Market Share of Cardiopulmonary Bypass Equipment by Type (2021–2032)
 Figure 70. Global Cardiopulmonary Bypass Equipment Price (K USD/Unit) by Type (2021–2032)
 Figure 71. Global Sales Market Share of Cardiopulmonary Bypass Equipment by Application (2021–2032)
 Figure 72. Global Revenue Market Share of Cardiopulmonary Bypass Equipment by Application (2021–2032)
 Figure 73. Global Cardiopulmonary Bypass Equipment Price (K USD/Unit) by Application (2021–2032)
 Figure 74. Cardiopulmonary Bypass Equipment Value Chain
 Figure 75. Channels of Distribution (Direct Vs Distribution)
 Figure 76. Bottom-up and Top-down Approaches for This Report
 Figure 77. Data Triangulation
 Figure 78. Key Executives Interviewed

以下、関連資料のご紹介